Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Molecular Cancer Therapeutics|February 1, 2017
Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven GliomasDamian A Almiron Bonnin, Cong Ran, Matthew C Havrda, et al.Neurological Research|June 14, 2005
Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirusTsuyoshi Tada, John Bang Nguyen, Yasuyuki Hitoshi, et al.Current Biology : CB|February 17, 2009
A role for Id2 in regulating photic entrainment of the mammalian circadian systemGiles E Duffield, Nathan P Watson, Akio Mantani, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesisMatthew C Havrda, Brent T Harris, Akio Mantani, et al.Cancer Research|January 16, 2014
Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironmentMatthew C Havrda, Brenton R Paolella, Cong Ran, et al.Cancer Research|March 5, 2003
Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumorsZhilan Hu, Jeannette M Bonifas, Geraldine Aragon, et al.Cancer Research|December 17, 2008
Cancer stem cells are enriched in the side population cells in a mouse model of gliomaMolly A Harris, Hyuna Yang, Benjamin E Low, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 15, 2011
Genetics of glioblastoma: a window into its imaging and histopathologic variabilityClifford J Belden, Pablo A Valdes, Cong Ran, et al.Journal of Magnetic Resonance Imaging : JMRI|March 14, 2002
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiformeAxel Gossmann, Thomas H Helbich, Nagato Kuriyama, et al.Plos One|December 7, 2013
Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastomaPingping Mao, Mary P Hever-Jardine, Gilbert J Rahme, et al.Pageof 4